ARCHIVES

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 28 No. 42 | November 15, 2002

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001